HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Veronique Dieras Selected Research

acridine DACA

8/2003Phase II study of XR5000 (DACA), an inhibitor of topoisomerase I and II, administered as a 120-h infusion in patients with advanced ovarian cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Veronique Dieras Research Topics

Disease

9Breast Neoplasms (Breast Cancer)
11/2020 - 11/2009
8Neoplasms (Cancer)
07/2019 - 09/2012
2Diarrhea
10/2018 - 11/2009
1Brain Neoplasms (Brain Tumor)
07/2019
1Endometrial Neoplasms (Endometrial Cancer)
01/2018
1Neutropenia
03/2017
1Thrombocytopenia (Thrombopenia)
03/2017
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
08/2014
1Colorectal Neoplasms (Colorectal Cancer)
08/2014
1Melanoma (Melanoma, Malignant)
08/2014
1Exanthema (Rash)
11/2009
1Disease Progression
11/2009
1Cardiotoxicity
04/2007
1Dyspnea (Shortness of Breath)
08/2003
1Fatigue
08/2003
1Cough
08/2003
1Ovarian Neoplasms (Ovarian Cancer)
08/2003
1Stomatitis
08/2003
1Nausea
08/2003
1Thrombosis (Thrombus)
08/2003

Drug/Important Bio-Agent (IBA)

3ErbB Receptors (EGF Receptor)IBA
10/2018 - 11/2009
2Ado-Trastuzumab EmtansineIBA
11/2019 - 01/2014
2Paclitaxel (Taxol)FDA LinkGeneric
10/2018 - 01/2017
2pertuzumabIBA
10/2018 - 01/2014
2CH 4987655IBA
08/2014 - 09/2012
2Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
08/2014 - 09/2012
1abemaciclibIBA
11/2020
1etirinotecan pegolIBA
07/2019
1taxaneIBA
07/2019
1AnthracyclinesIBA
07/2019
1Capecitabine (Xeloda)FDA Link
07/2019
1Loperamide (Imodium)FDA LinkGeneric
10/2018
1lumretuzumabIBA
10/2018
1onapristoneIBA
01/2018
1Progesterone Receptors (Progesterone Receptor)IBA
01/2018
1rucaparibIBA
03/2017
1Carboplatin (JM8)FDA LinkGeneric
03/2017
1Bevacizumab (Avastin)FDA Link
01/2017
1NeuregulinsIBA
01/2014
1Drug CombinationsIBA
01/2014
1Neuregulin-1 (Neuregulin 1)IBA
01/2014
1LigandsIBA
01/2014
1Proteins (Proteins, Gene)FDA Link
09/2012
1MitogensIBA
09/2012
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
09/2012
1Trastuzumab (Herceptin)FDA Link
01/2011
1EverolimusFDA Link
01/2011
1Vinorelbine (Navelbine)FDA LinkGeneric
01/2011
1Lapatinib (GW572016)FDA Link
11/2009
1Letrozole (Femara)FDA LinkGeneric
11/2009
1Epidermal Growth Factor (EGF)IBA
11/2009
1human ERBB2 proteinIBA
11/2009
1Tyrosine Kinase InhibitorsIBA
11/2009
1Aromatase InhibitorsIBA
11/2009
1Hormones (Hormone)IBA
11/2009
1SR 271425IBA
04/2007
1acridine DACAIBA
08/2003
1Cytotoxins (Cytolysins)IBA
08/2003
1Taxoids (Taxanes)IBA
08/2003
1Pharmaceutical PreparationsIBA
08/2003
1PlatinumIBA
08/2003
1DNA (Deoxyribonucleic Acid)IBA
08/2003
1Type I DNA Topoisomerases (Topoisomerase I)IBA
08/2003

Therapy/Procedure

7Therapeutics
03/2017 - 08/2003
2Drug Therapy (Chemotherapy)
11/2020 - 08/2003
1Duration of Therapy
01/2018